Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 23;11(10):2944.
doi: 10.3390/jcm11102944.

Preoperative Imaging with [18F]-Fluorocholine PET/CT in Primary Hyperparathyroidism

Affiliations

Preoperative Imaging with [18F]-Fluorocholine PET/CT in Primary Hyperparathyroidism

Franziska J Dekorsy et al. J Clin Med. .

Abstract

Primary hyperparathyroidism (pHPT) is a common endocrine disorder due to hyperfunctioning parathyroid glands. To date, the only curing therapy is surgical removal of the dysfunctional gland, making correct detection and localization crucial in order to perform a minimally invasive parathyroidectomy. 18F-Fluorocholine positron emission tomography/computed tomography (18F-FCH PET/CT) has shown promising results for the detection of pHPT, suggesting superiority over conventional imaging with ultrasounds or scintigraphy. A total of 33 patients with pHPT who had negative or equivocal findings in conventional imaging received 18F-FCH PET/CT preoperatively and were retrospectively included. A pathological hyperfunctional parathyroid gland was diagnosed in 24 cases (positive PET, 72.7%), 4 cases showed equivocal choline uptake (equivocal PET, 12.1%), and in 5 cases, no enhanced choline uptake was evident (negative PET, 15.2%). Twelve of the twenty-four detected adenoma patients underwent surgery, and in all cases, a pathological parathyroid adenoma was resected at the site detected by PET/CT. Two of the six patients without pathological choline uptake who received a parathyroidectomy revealed no evidence of parathyroid adenoma tissue in the histopathological evaluation. This retrospective study analyzes 18F-FCH PET/CT in a challenging patient cohort with pHPT and negative or equivocal conventional imaging results and supports the use of 18F-FCH for the diagnosis of hyperfunctional parathyroid tissue, especially in this patient setting, with a 100% true positive and true negative detection rate. Our study further demonstrates the importance of 18F-FCH PET/CT for successful surgical guidance.

Keywords: fluorocholine PET/CT; noninvasive imaging; parathyroid adenoma.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Patient selection flow chart.
Figure 2
Figure 2
Patient examples of positive (A), equivocal (B), and negative (C) 18F-Fluorocholine PET/CT; PET (1), CT (2), and fused images of PET and CT (3). (A) a focal choline uptake correlating to a contrast enhanced lesion in the caudal left thyroid bed was detectable. (B) only weak and diffused choline uptake of the right thyroid tissue was visual. (C) no enhanced choline uptake was detectable.
Figure 3
Figure 3
Significant positive correlation of the axial CT diameter (cm) with the SUVmax of parathyroid adenoma.
Figure 4
Figure 4
Laboratory results of the three groups of positive, equivocal, and negative PET/CT images. The group after successful resection showed a highly significant decrease in serum calcium and parathyroid hormone; *** = p < 0.001.

References

    1. Yu N., Donnan P.T., Murphy M.J., Leese G.P. Epidemiology of primary hyperparathyroidism in Tayside, Scotland, UK. Clin. Endocrinol. 2009;71:485–493. doi: 10.1111/j.1365-2265.2008.03520.x. - DOI - PubMed
    1. Adami S., Marcocci C., Gatti D. Epidemiology of primary hyperparathyroidism in Europe. J. Bone Miner. Res. 2002;17((Suppl. S2)):N18–N23. - PubMed
    1. Lundgren E., Rastad J., Thrufjell E., Akerström G., Ljunghall S. Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women. Surgery. 1997;121:287–294. doi: 10.1016/S0039-6060(97)90357-3. - DOI - PubMed
    1. Ruda J.M., Hollenbeak C.S., Stack B.C., Jr. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol. Neck Surg. 2005;132:359–372. doi: 10.1016/j.otohns.2004.10.005. - DOI - PubMed
    1. Bilezikian J.P., Brandi M.L., Eastell R., Silverberg S.J., Udelsman R., Marcocci C., Potts J.T., Jr. Metabolism. Guidelines for the management of asymptomatic primary hyperparathyroidism: Summary statement from the Fourth International Workshop. J. Clin. Endocrinol. Metab. 2014;99:3561–3569. doi: 10.1210/jc.2014-1413. - DOI - PMC - PubMed

LinkOut - more resources